Econazole nitrate and triamcinolone acetonide are combined in a topical formulation used for treating various dermatological conditions. Econazole nitrate is an antifungal agent, while triamcinolone acetonide is a corticosteroid. This combination is effective in treating fungal infections with associated inflammation or itching.
The combination of econazole nitrate and triamcinolone acetonide is used to treat:
| Brand Name | Stenide |
|---|---|
| Type | Cream |
| Weight | 1%+0.1% |
| Generic | Econazole Nitrate + Triamcinolone Acetonide |
| Manufacturer | Navana Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Econazole nitrate works by inhibiting the synthesis of ergosterol, a crucial component of fungal cell membranes, leading to the death of the fungus. Triamcinolone acetonide, a corticosteroid, reduces inflammation, redness, and itching by suppressing the immune response and decreasing the production of inflammatory mediators.
The efficacy of the treatment can be observed within 1-2 weeks of application. However, complete resolution of symptoms may take longer, depending on the severity of the infection and the response to therapy.
When applied topically, econazole nitrate and triamcinolone acetonide are minimally absorbed through the skin. The systemic absorption is usually low, which minimizes the risk of systemic side effects.
The drugs are primarily eliminated through the skin and are excreted in small amounts in the urine. Triamcinolone acetonide, if absorbed systemically, is metabolized in the liver and excreted in the urine.
Apply the combination cream to the affected area once or twice daily, depending on the severity of the condition and the specific instructions from a healthcare provider. The duration of treatment typically ranges from 2 to 4 weeks, but may be adjusted based on clinical response and tolerability.
The cream should be applied in a thin layer to the affected skin areas. It should be gently rubbed in until fully absorbed. Avoid applying to broken or irritated skin and do not use occlusive dressings unless directed by a healthcare provider.
Common side effects include:
Topical application of econazole nitrate and triamcinolone acetonide has a low risk of toxicity due to minimal systemic absorption. Overuse or improper application may lead to local skin reactions or potential systemic effects if significant amounts are absorbed.
Precautions include:
Drug interactions are minimal due to the topical route of administration. However, concurrent use of other topical medications should be monitored to avoid potential interactions.
Use with caution in patients with:
Minimal drug interactions are expected with other topical medications. Systemic interactions are unlikely due to low systemic absorption.
There are no known food interactions with the topical use of econazole nitrate and triamcinolone acetonide.
The safety of this combination during pregnancy is not well established. It should be used during pregnancy only if clearly needed and if the benefits outweigh the risks. Consult a healthcare provider for a risk assessment.
It is not known whether the topical application of this combination affects breast milk or nursing infants. Caution is advised, and a healthcare provider should be consulted before use during lactation.
Acute overdose is unlikely due to the topical route of administration. In case of accidental ingestion or excessive application, seek medical advice. Treatment will be symptomatic and supportive.
The combination is contraindicated in individuals with:
Apply the cream as directed by a healthcare provider. Avoid applying to open wounds or sensitive areas. Follow the prescribed treatment duration to avoid relapse of the infection or worsening of symptoms.
Store the cream at room temperature, between 15°C and 30°C (59°F and 86°F). Keep the container tightly closed and protect from light. Keep out of reach of children.
The volume of distribution for the topical formulation is not well characterized, but systemic absorption is minimal.
The half-life of econazole nitrate and triamcinolone acetonide is not directly applicable due to their topical use and minimal systemic absorption. For systemic formulations, triamcinolone has a half-life of approximately 2-4 hours.
The clearance of the topical formulation is not well defined. Systemic clearance of triamcinolone is primarily through hepatic metabolism and renal excretion.
See in details version Stenide Cream 1%+0.1% also Stenide Cream 1%+0.1% in bangla